Report cover image

Multiple Myeloma Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published Jan 01, 2025
Length 110 Pages
SKU # FOB19847094

Description

Growth Factors of Multiple Myeloma Market

Multiple myeloma (MM) is a rare yet significant form of blood cancer, accounting for a notable number of cancer cases worldwide. The global multiple myeloma market was valued at USD 19.48 billion in 2018 and is projected treach USD 31.00 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.0% during the forecast period.

Key Market Drivers

1. Increasing Prevalence of Multiple Myeloma: The rising incidence of MM globally has heightened the demand for effective and advanced therapeutics. Early diagnosis and treatment are crucial, as untreated MM can lead tfatal outcomes. The growing awareness of disease symptoms has contributed thigher diagnosis rates, thereby expanding the patient pool requiring treatment.

2. Advancements in Drug Development: Significant investments in research and development have led tthe introduction of several blockbuster drugs, enhancing treatment options for MM patients. The focus on novel therapies aims timprove patient outcomes and address unmet clinical needs. For instance, the development of bispecific antibodies like REGN5458 has shown promising results in clinical trials.

3. Robust Pipeline of Therapeutics: Pharmaceutical companies are actively engaged in developing new treatments for MM, with numerous clinical trials underway. The strong pipeline reflects the commitment tintroducing innovative therapies that can offer better efficacy and safety profiles. The anticipated introduction of more advanced therapeutics is expected tfuel market growth.

Market Segmentation

The multiple myeloma market is segmented based on drug class and distribution channel:
  • By Drug Class:
Immunomodulators

Proteasome Inhibitors

Anti-CD38 Monoclonal Antibodies

Alkylating Agents

Others
  • By Distribution Channel:
Hospital Pharmacies

Retail Pharmacies & Drug Stores

Online Pharmacies

Among these, the immunomodulators segment is expected tlead the market during the forecast period, driven by their efficacy in treatment protocols.

Regional Insights

North America dominated the multiple myeloma market in 2018, attributed tthe high prevalence of the disease, advanced healthcare infrastructure, and significant investment in research and development. The region's proactive approach tadopting new therapies has alscontributed tits leading position.

Europe holds the second-largest market share, supported by increasing awareness and availability of advanced treatments. The Asia-Pacific region is anticipated texhibit the highest growth rate during the forecast period, owing tthe rising healthcare expenditure, improving healthcare infrastructure, and growing awareness about multiple myeloma.

Competitive Landscape

The multiple myeloma market is characterized by the presence of several key players focusing on expanding their product portfolios and geographical reach. Some of the leading companies include:
  • CELGENE CORPORATION (Bristol Myers Squibb Company)
  • Amgen Inc.
  • Janssen Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Sanofi
  • AbbVie Inc.
  • Karyopharm Therapeutics
These companies are investing in strategic collaborations, mergers, and acquisitions tstrengthen their market position. For example, in April 2019, the Multiple Myeloma Research Foundation (MMRF) introduced the 'Myeloma Investment Fund' tadvance research activities related tmultiple myeloma.

Future Outlook

The multiple myeloma market is poised for significant growth, driven by the increasing prevalence of the disease, advancements in therapeutic options, and a strong pipeline of novel treatments. The anticipated introduction of more advanced therapeutics, coupled with increased awareness and early diagnosis, is expected tfuel the demand for multiple myeloma treatment products.

Moreover, the expansion of distribution channels, including online pharmacies, is likely tenhance accessibility ttreatments, further propelling market growth. As research continues tevolve, the focus remains on developing therapies that offer improved efficacy, safety, and quality of life for patients battling multiple myeloma.

In conclusion, the multiple myeloma market is undergoing transformative growth, underpinned by scientific advancements and a concerted effort taddress the challenges associated with this complex disease. The collaborative endeavors of pharmaceutical companies, research institutions, and healthcare providers are pivotal in shaping a promising future for multiple myeloma treatment and management.

ATTRIBUTE DETAILS

Study Period - 2015-2026

Base Year - 2018

Forecast Period - 2019-2026

Historical Period - 2015-2017

Unit - Value (USD billion)

Segmentation By Drug Class
  • Immunomodulators
  • Proteasome Inhibitor
  • Anti-CD38 Monoclonal Antibody
  • Alkylating Agents
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies
By Geography
  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia-Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

110 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Venous Leg Ulcer, DVT, Lymphedema and other key indications by country/region
4.2. Key Industry Trends
4.3. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
4.4. New Product Launches
5. Global Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product
5.2.1. Compression Garments
5.2.1.1. Compression Bandages
5.2.1.2. Compression Stockings
5.2.1.3. Others
5.2.2. Compression Pumps
5.2.3. Others
5.3. Market Analysis, Insights and Forecast – By Application
5.3.1. Venous Leg Ulcer
5.3.2. Deep Vein Thrombosis
5.3.3. Lymphedema
5.3.4. Others
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Hospitals & Clinics
5.4.2. Nursing Care Centers
5.4.3. Home Care
5.4.4. Others
5.5. Market Analysis, Insights and Forecast – By Country
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Product
6.2.1. Compression Garments
6.2.1.1. Compression Bandages
6.2.1.2. Compression Stockings
6.2.1.3. Others
6.2.2. Compression Pumps
6.2.3. Others
6.3. Market Analysis – By Application
6.3.1. Venous Leg Ulcer
6.3.2. Deep Vein Thrombosis
6.3.3. Lymphedema
6.3.4. Others
6.4. Market Analysis – By End User
6.4.1. Hospitals & Clinics
6.4.2. Nursing Care Centers
6.4.3. Home Care
6.4.4. Others
6.5. Market Analysis – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Product
7.2.1. Compression Garments
7.2.1.1. Compression Bandages
7.2.1.2. Compression Stockings
7.2.1.3. Others
7.2.2. Compression Pumps
7.2.3. Others
7.3. Market Analysis – By Application
7.3.1. Venous Leg Ulcer
7.3.2. Deep Vein Thrombosis
7.3.3. Lymphedema
7.3.4. Others
7.4. Market Analysis – By End User
7.4.1. Hospitals & Clinics
7.4.2. Nursing Care Centers
7.4.3. Home Care
7.4.4. Others
7.5. Market Analysis – By Country/Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Product
8.2.1. Compression Garments
8.2.1.1. Compression Bandages
8.2.1.2. Compression Stockings
8.2.1.3. Others
8.2.2. Compression Pumps
8.2.3. Others
8.3. Market Analysis – By Application
8.3.1. Venous Leg Ulcer
8.3.2. Deep Vein Thrombosis
8.3.3. Lymphedema
8.3.4. Others
8.4. Market Analysis – By End User
8.4.1. Hospitals & Clinics
8.4.2. Nursing Care Centers
8.4.3. Home Care
8.4.4. Others
8.5. Market Analysis – By Country/Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Product
9.2.1. Compression Garments
9.2.1.1. Compression Bandages
9.2.1.2. Compression Stockings
9.2.1.3. Others
9.2.2. Compression Pumps
9.2.3. Others
9.3. Market Analysis – By Application
9.3.1. Venous Leg Ulcer
9.3.2. Deep Vein Thrombosis
9.3.3. Lymphedema
9.3.4. Others
9.4. Market Analysis – By End User
9.4.1. Hospitals & Clinics
9.4.2. Nursing Care Centers
9.4.3. Home Care
9.4.4. Others
9.5. Market Analysis – By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis – By Product
10.2.1. Compression Garments
10.2.1.1. Compression Bandages
10.2.1.2. Compression Stockings
10.2.1.3. Others
10.2.2. Compression Pumps
10.3. Others
10.4. Market Analysis – By Application
10.4.1. Venous Leg Ulcer
10.4.2. Deep Vein Thrombosis
10.4.3. Lymphedema
10.4.4. Others
10.5. Market Analysis – By End User
10.5.1. Hospitals & Clinics
10.5.2. Nursing Care Centers
10.5.3. Home Care
10.5.4. Others
10.6. Market Analysis – By Country/Sub-region
10.6.1. GCC Countries
10.6.2. South Africa
10.6.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.1. SIGVARIS
11.5.1.1. Overview,
11.5.1.2. Products & services,
11.5.1.3. SWOT analysis,
11.5.1.4. Recent developments,
11.5.1.5. strategies,
11.5.1.6. financials (based on availability)
11.5.2. 3M
11.5.2.1. Overview,
11.5.2.2. Products & services,
11.5.2.3. SWOT analysis,
11.5.2.4. Recent developments,
11.5.2.5. strategies,
11.5.2.6. financials (based on availability)
11.5.3. Arjo
11.5.3.1. Overview,
11.5.3.2. Products & services,
11.5.3.3. SWOT analysis,
11.5.3.4. Recent developments,
11.5.3.5. strategies,
11.5.3.6. financials (based on availability)
11.5.4. PAUL HARTMANN Pty. Ltd
11.5.4.1. Overview,
11.5.4.2. Products & services,
11.5.4.3. SWOT analysis,
11.5.4.4. Recent developments,
11.5.4.5. strategies,
11.5.4.6. financials (based on availability)
11.5.5. medi GmbH & Co. KG
11.5.5.1. Overview,
11.5.5.2. Products & services,
11.5.5.3. SWOT analysis,
11.5.5.4. Recent developments,
11.5.5.5. strategies,
11.5.5.6. financials (based on availability)
11.5.6. Essity Aktiebolag (publ)
11.5.6.1. Overview,
11.5.6.2. Products & services,
11.5.6.3. SWOT analysis,
11.5.6.4. Recent developments,
11.5.6.5. strategies,
11.5.6.6. financials (based on availability)
11.5.7. Smith & Nephew
11.5.7.1. Overview,
11.5.7.2. Products & services,
11.5.7.3. SWOT analysis,
11.5.7.4. Recent developments,
11.5.7.5. strategies,
11.5.7.6. financials (based on availability)
11.5.8. Bio Compression Systems, Inc.
11.5.8.1. Overview,
11.5.8.2. Products & services,
11.5.8.3. SWOT analysis,
11.5.8.4. Recent developments,
11.5.8.5. strategies,
11.5.8.6. financials (based on availability)
11.5.9. Tactile Systems Technology, Inc.
11.5.9.1. Overview,
11.5.9.2. Products & services,
11.5.9.3. SWOT analysis,
11.5.9.4. Recent developments,
11.5.9.5. strategies,
11.5.9.6. financials (based on availability)
11.5.10. Other Players
11.5.10.1. Overview,
11.5.10.2. Products & services,
11.5.10.3. SWOT analysis,
11.5.10.4. Recent developments,
11.5.10.5. strategies,
11.5.10.6. financials (based on availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us